Summary
Eli Lilly and Company (LLY) filed an 8-K on April 24, 2014, to report its first-quarter 2014 financial results. The filing primarily serves to attach a press release detailing these results and to inform investors about the company's use of non-GAAP financial measures. These non-GAAP measures, such as non-GAAP net income and earnings per share, are presented alongside GAAP figures to offer a clearer view of ongoing operations and facilitate meaningful comparisons over time by excluding highly variable or unpredictable items. Investors should note that the company utilizes these non-GAAP metrics for internal performance evaluation, resource allocation, and incentive compensation. While Lilly believes these measures provide valuable insights for investors in assessing operational trends, it is crucial for investors to consider them in conjunction with, and not as a replacement for, the standard GAAP financial measures. The information provided in this 8-K is furnished and not deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934.
Key Highlights
- 1Filing of an 8-K to report Q1 2014 financial results, dated April 24, 2014.
- 2The report includes a press release announcing Q1 2014 operational results and income statements.
- 3Eli Lilly & Co. uses and explains its use of non-GAAP financial measures (e.g., non-GAAP net income, EPS).
- 4Non-GAAP measures are presented to provide investors with insights into ongoing operations and facilitate period-over-period comparisons.
- 5The company believes non-GAAP measures help identify operating trends that might be obscured by GAAP figures.
- 6Management uses non-GAAP metrics internally for performance evaluation and resource allocation.
- 7Information provided is furnished, not filed for Section 18 purposes.